These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35938144)

  • 21. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
    Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Hartnett ME; Cohen G;
    Ophthalmology; 2011 Feb; 118(2):345-52. PubMed ID: 20926135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case Report: A Case of Cystoid Macular Edema in Retinitis Pigmentosa With Central Retinal Vein Occlusion.
    Wang DH; Gu C; Yuan YZ
    Front Med (Lausanne); 2022; 9():877429. PubMed ID: 35755060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study.
    Campochiaro PA; Sophie R; Pearlman J; Brown DM; Boyer DS; Heier JS; Marcus DM; Feiner L; Patel A;
    Ophthalmology; 2014 Jan; 121(1):209-219. PubMed ID: 24112944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion.
    Kida T; Morishita S; Kakurai K; Suzuki H; Oku H; Ikeda T
    Clin Ophthalmol; 2014; 8():955-8. PubMed ID: 24876761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
    Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
    JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intravitreal anti-vascular endothelial growth factor treatment on retinal vasculature in retinal vein occlusion as determined by ultra wide-field fluorescein angiography.
    Vance SK; Chang LK; Imamura Y; Freund KB
    Retin Cases Brief Rep; 2011; 5(4):343-7. PubMed ID: 25390431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion.
    Guo S; Ren J; Li Z; Fan X; Qin L; Li J
    Acta Ophthalmol; 2019 May; 97(3):273-278. PubMed ID: 30803163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined central retinal vein occlusion and branch retinal artery occlusion treated with intravitreal dexamethasone implant: A case report.
    Arrigo A; Knutsson KA; Rajabjan F; Augustin VA; Bandello F; Parodi MB
    Eur J Ophthalmol; 2021 Mar; 31(2):NP74-NP76. PubMed ID: 32106703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
    Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
    Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab.
    Sakanishi Y; Lee A; Usui-Ouchi A; Ito R; Ebihara N
    Clin Ophthalmol; 2016; 10():1161-5. PubMed ID: 27382250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
    Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
    Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.
    Hoeh AE; Ach T; Schaal KB; Scheuerle AF; Dithmar S
    Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1635-41. PubMed ID: 19633982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
    Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photocoagulation for retinal vein occlusion.
    Hayreh SS
    Prog Retin Eye Res; 2021 Nov; 85():100964. PubMed ID: 33713810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QUALITATIVE AND QUANTITATIVE FOLLOW-UP USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VEIN OCCLUSION TREATED WITH ANTI-VEGF: Optical Coherence Tomography Angiography Follow-up of Retinal Vein Occlusion.
    Sellam A; Glacet-Bernard A; Coscas F; Miere A; Coscas G; Souied EH
    Retina; 2017 Jun; 37(6):1176-1184. PubMed ID: 27685676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cilioretinal artery occlusion and central retinal vein occlusion complicating hyperhomocysteinemia: a case report].
    Berkani Z; Kitouni Y; Belhadj A; Sifi K; Abbadi N; Bellatrache C; Hartani D; Kherroubi R
    J Fr Ophtalmol; 2013 Sep; 36(7):e119-27. PubMed ID: 23731792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Foveal Eversion is Associated with High Persistence of Macular Edema and Visual Acuity Deterioration in Retinal Vein Occlusion.
    Arrigo A; Aragona E; Antropoli A; Bianco L; Rosolia A; Saladino A; Bandello F; Battaglia Parodi M
    Ophthalmol Ther; 2023 Aug; 12(4):2157-2169. PubMed ID: 37294523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography.
    Bhisitkul RB; Campochiaro PA; Shapiro H; Rubio RG
    Ophthalmology; 2013 May; 120(5):1057-63. PubMed ID: 23415775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Conbercept Treatment on Macular Edema and Microvascular Structure in Eyes with Retinal Vein Occlusions.
    Ding X; Wang Y; Zou B; Zang D; Hao Y
    Int J Gen Med; 2022; 15():7311-7318. PubMed ID: 36133911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.